[Asia Economy Reporter Myung-Hwan Lee] Medytox announced on the 17th that it has decided to acquire 41,771 common shares on the market for 4,999,990,000 KRW to stabilize its stock price and enhance shareholder value.



The expected acquisition period is from the 18th to November 15th.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing